Given my previous post regarding budesonide and asthma preventors, EXO-CD24 COVID treatment also begins its work in the lungs.

So far, only Phase 1 trials have been conducted. Phases 2 and 3 will follow. At this stage, though, tests are promising.

From the article...

Quote:
Hailing a “huge breakthrough,” the hospital said Prof. Nadir Arber’s EXO-CD24 substance had been administered to 30 patients whose conditions were moderate or worse, and all 30 recovered — 29 of them within three to five days.

https://www.timesofisrael.com/new-israeli-drug-cured-moderate-to-serious-covid-cases-within-days-hospital/

Regards,
Noel


MY SONGS...
Audiophile BIAB 2024